Madrigal Pharmaceuticals, Inc. (MDGL)
| Previous close | 213.49 |
| Open | 212.82 |
| Bid | 219.27 x 100 |
| Ask | 221.05 x 100 |
| Day's range | 210.10 - 225.66 |
| 52-week range | 119.76 - 322.67 |
| Volume | |
| Avg. volume | 581,887 |
| Market cap | 4.618B |
| Beta (5Y monthly) | -0.44 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -19.98 |
| Earnings date | 07 May 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 377.07 |
GlobeNewswireMadrigal Pharmaceuticals to Release First-Quarter 2024 Financial Results and Host Webcast on May 7, 2024
CONSHOHOCKEN, Pa., April 23, 2024 (GLOBE NEWSWIRE) -- Madrigal Pharmaceuticals, Inc. (Nasdaq: MDGL) announced today that it will release its first-quarter 2024 financial results on Tuesday, May 7, 2024, prior to the open of the U.S. financial markets. Following the announcement, Madrigal’s management will host a live webcast at 8 a.m. Eastern Time to review the Company’s financial and operating results. The live webcast may be accessed at the Investor Relations section of the Madrigal Pharmaceut
- GlobeNewswire
Madrigal Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
CONSHOHOCKEN, Pa., April 16, 2024 (GLOBE NEWSWIRE) -- Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL), a biopharmaceutical company pursuing novel therapeutics for nonalcoholic steatohepatitis (NASH), today announced that the company granted equity awards to 7 new employees, in each case with a grant date of April 15, 2024, as equity inducement awards under the terms of the company's 2023 Inducement Plan. The equity awards were approved in accordance with Nasdaq Listing Rule 5635(c)(4). The equity a
Insider MonkeyLatest Insider Selling in April 2024: 10 Stocks to Watch
In this article, we will take a detailed look at Latest Insider Selling in April 2024: 10 Stocks to Watch. For a quick overview of the 5 such stocks, read our article Latest Insider Selling in April 2024: 5 Stocks to Watch. Wall Street analysts and wise investors often keep a close eye on insider buying and selling, […]
